Drug Delivery via the Suprachoroidal Space for the Treatment of Retinal Diseases
Open accessThe DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Abstract
The suprachoroidal space (SCS), a potential space between the sclera and choroid, is becoming an applicable method to deliver therapeutics to the back of the eye. In recent years, a vast amount of research in the field has been carried out, with new discoveries in different areas of interest, such as imaging, drug delivery methods, pharmacokinetics, pharmacotherapies in preclinical and clinical trials and advanced therapies. The SCS can be visualized via advanced techniques of optical coherence tomography (OCT) in eyes with different pathologies, and even in healthy eyes. Drugs can be delivered easily and safely via hollow microneedles fitted to the length of the approximate thickness of the sclera. SCS injections were found to reach greater baseline concentrations in the target layers compared to intravitreal (IVT) injection, while agent clearance was faster with highly aqueous soluble molecules. Clinical trials with SCS injection of triamcinolone acetonide (TA) were executed with promising findings for patients with noninfectious uveitis (NIU), NIU implicated with macular edema and diabetic macular edema (DME). Gene therapy is evolving rapidly with viral and non-viral vectors that were found to be safe and efficient in preclinical trials. Here, we review these novel different aspects and new developments in clinical treatment of the posterior segment of the eye.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Different ocular drug administration routs; (1) topical route, (2) subconjunctival route, (3) suprachoroidal route with microcannula and microneedle, (4) subretinal route and (5) intravitreal injection. Reproduced from [5], CC BY 4.0 license, Published by MDPI 2021.](https://figures.cochat.ai/paper-figures/bc7286a15e24443f8f64ce0b2cfb23bb/drug-delivery-via-the-suprachoroidal-space-for-the-treatment-of-retinal-diseases-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This injection requires a skilled surgeon and must be performed in an operating room. Procedure-related adverse events include suprachoroidal hemorrhage, endophthalmitis, choroidal tears, changes in choroidal blood flow, inflammation, and retinal detachment.131”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [131]
In the citing paper
“Suprachoroidal injections, administered between the choroid and sclera, do not require vitreoretinal surgeries, and show better bioavailability than intravitreal injections.1,131,132”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [131]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hydrogel: Preparation, characterization, and applications: A review
Ahmed, E. M. (2015) · Journal of Advanced Research · doi:10.1016/j.jare.2013.07.006 · Cited by 5,800 · cited 1×
“A hydrogel is a network of crosslinked polymer chains that are hydrophilic and capable of holding large amounts of water due to their structure [60].”
BackgroundGlobal estimates of visual impairment: 2010
Pascolini, D., & Mariotti, S. P. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-300539 · Cited by 3,763
Enhanced Depth Imaging Spectral-Domain Optical Coherence Tomography
Spaide, R. F., Koizumi, H., & Pozonni, M. C. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.05.032 · Cited by 2,180
Hyaluronic Acid Hydrogels for Biomedical Applications
Burdick, J. A., & Prestwich, G. D. (2011) · Advanced Materials · doi:10.1002/adma.201003963 · Cited by 2,139 · cited 1×
“Hyaluronic acid (HA) hydrogels are used frequently for sustained ocular drug delivery [61].”
BackgroundMicroneedles: A smart approach and increasing potential for transdermal drug delivery system
Waghule, T., Singhvi, G., Dubey, S. K., Pandey, M. M., Gupta, G., Singh, M., & Dua, K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.078 · Cited by 1,260 · cited 1×
“They have an empty space inside which is filled with the drug dispersion or solution and have holes at the tips (Figure 3) [41].”
BackgroundViral and nonviral delivery systems for gene delivery
Nayerossadat, N., Maedeh, T., & Ali, P. (2012) · Advanced Biomedical Research · doi:10.4103/2277-9175.98152 · Cited by 858 · cited 1×
“Viral gene delivery utilizes the ability of a virus to inject its DNA into a host cell and to deliver the desired genetic material into the nucleus for replication [90].”
BackgroundPharmacokinetic aspects of retinal drug delivery
del Amo, E. M., Rimpelä, A.-K., Heikkinen, E., Kari, O. K., Ramsay, E., Lajunen, T., Schmitt, M., Pelkonen, L., Bhattacharya, M., Richardson, D., et al. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.12.001 · Cited by 693 · cited 2×
“The SCS is the potential space lying between the sclera and choroid [7].”
BackgroundA combinatorial polymer library approach yields insight into nonviral gene delivery
Green, J. J., Langer, R., & Anderson, D. G. (2008) · Accounts of Chemical Research · doi:10.1021/ar7002336 · Cited by 579
Current and future ophthalmic drug delivery systems
del Amo, E. M., & Urtti, A. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.11.002 · Cited by 414 · cited 1×
“IVT injection is easy to administer and can be performed in an office setting; however, it does not target a specific area and has adverse effects, including endophthalmitis, elevated intraocular pressure (IOP) and cataract progression [6].”
BackgroundSuprachoroidal drug delivery to the back of the eye using hollow microneedles
Patel, S. R., Lin, A. S. P., Edelhauser, H. F., & Prausnitz, M. R. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0271-y · Cited by 330 · cited 1×
“[11] showed the applicability of hollow microneedles for injecting drugs into the SCS.”
Background
Research works printed but not linked: 2
- 17. Michalewska, Z.; Michalewski, J.; Nawrocki, J. Retinal Physician-Going Deeper and Wider. Retin. Physician 2013 , 10 , 42-48.
- 9. suspension) in rabbits. iOVS 2020 , 61 , 4925.
Cited by
Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications
Zhang, J., Zhang, J., Zhang, C., Zhang, J., Gu, L., Luo, D., & Qiu, Q. (2022) · Cells · doi:10.3390/cells11213362 · Cited by 300
Long-acting microneedle formulations
Vora, L. K., Sabri, A. H., Naser, Y., Himawan, A., Hutton, A. R. J., Anjani, Q. K., Volpe-Zanutto, F., Mishra, D., Li, M., Rodgers, A. M., et al. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115055 · Cited by 166
Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions
Drag, S., Dotiwala, F., & Upadhyay, A. K. (2023) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.64.7.39 · Cited by 145
Bairagi, R. D., Reon, R. R., Hasan, M. M., Sarker, S. K., Debnath, D., Rahman, M. T., Rahman, S., Islam, M. A., Siddique, M. A. T., Bokshi, B., et al. (2025) · Discover Nano · doi:10.1186/s11671-025-04234-6 · Cited by 94
“Moreover, the use of collagen shields has become important in transferring plasmid DNA into the bleb following glaucoma surgery to control wound healing [275].”
Suprachoroidal Injection: A Novel Approach for Targeted Drug Delivery
Wu, K. Y., Fujioka, J. K., Gholamian, T., Zaharia, M., & Tran, S. D. (2023) · Pharmaceuticals · doi:10.3390/ph16091241 · Cited by 69
“Hollow microneedles are miniature devices used primarily for transdermal drug delivery [7,13].”
BackgroundMethodInfluentialVesicular Drug Delivery Systems: Promising Approaches in Ocular Drug Delivery
Batur, E., Özdemir, S., Durgun, M. E., & Özsoy, Y. (2024) · Pharmaceuticals · doi:10.3390/ph17040511 · Cited by 74
“Suprachoroidal administration is applied for implants, microneedles, and other formulations, directing the drug between the sclera and choroid to reduce systemic side effects [29–31].”
BackgroundSix-month sustained delivery of anti-VEGF from in-situ forming hydrogel in the suprachoroidal space
Jung, J. H., Kim, S. S., Chung, H., Hejri, A., & Prausnitz, M. R. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.10.036 · Cited by 48
Hashida, N., & Nishida, K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114870 · Cited by 38
Smart molecules in ophthalmology: Hydrogels as responsive systems for ophthalmic applications
Kulbay, M., Wu, K. Y., Truong, D., & Tran, S. D. (2024) · Smart Molecules · doi:10.1002/smo.20230021 · Cited by 49
Hydrogels in Ophthalmology: Novel Strategies for Overcoming Therapeutic Challenges
Wu, K. Y., Akbar, D., Giunta, M., Kalevar, A., & Tran, S. D. (2023) · Materials · doi:10.3390/ma17010086 · Cited by 37
“Furthermore, this approach selectively compartmentalizes the treatment area, thereby reducing the likelihood of corticosteroid-related complications, such as the development of cataracts and the elevation of IOP [94,97,98].”
BackgroundA New Generation of Gene Therapies as the Future of Wet AMD Treatment
Błasiak, J., Pawłowska, E., Ciupińska, J., Derwich, M., Szczepańska, J., & Kaarniranta, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042386 · Cited by 33
Mulkutkar, M., Damani, M., & Sawarkar, S. P. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114209 · Cited by 29
Tabl, A. A., Soliman, T. T., Elsayed, M. A., & Tabl, M. A. (2022) · Journal of Ophthalmology · doi:10.1155/2022/7947710 · Cited by 31
Novel Approaches in the Drug Development and Delivery Systems for Age-Related Macular Degeneration
Paliwal, H., Prajapati, B. G., Srichana, T., Singh, S. K., & Patel, R. J. (2023) · Life · doi:10.3390/life13020568 · Cited by 22
The Future of Stem Cells and Their Derivates in the Treatment of Glaucoma. A Critical Point of View
Nicoară, S., Brie, I. C., Jurj, A. M., & Şoriţău, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011077 · Cited by 20
“The most promising method for SCS administration is the use of microneedles whose length are designed to fit the approximate thickness of the sclera and have important advantages: minimally invasive, very good safety profile, simple to use, less painful, inexpensive [78].”
MethodCiorba, A. L., Saber, S., Abdelhamid, A. M., Keshk, N., Elnaghy, F., Elmorsy, E. A., Abu‐Khudir, R., Hamad, R. S., Abdel‐Reheim, M. A., Farrag, A. A. M., et al. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107307 · Cited by 25
Suprachoroidal Delivery in Rats and Guinea Pigs Using a High-Precision Microneedle Injector
Hejri, A., Bowland, I. I., Nickerson, J. M., & Prausnitz, M. R. (2023) · Translational Vision Science & Technology · doi:10.1167/tvst.12.3.31 · Cited by 16
Suprachoroidal injection of polyzwitterion hydrogel for treating glaucoma
Hao, H., He, B., Yu, B., Yang, J., Xing, X., & Liu, W. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213162 · Cited by 14
Yeh, S., Henry, C. R., Kapik, B. M., & Ciulla, T. A. (2022) · Ophthalmology and Therapy · doi:10.1007/s40123-022-00603-x · Cited by 15
SUPRACHOROIDAL SPACE INJECTION TECHNIQUE: Expert Panel Guidance
Wykoff, C. C., Avery, R. L., Barakat, M., Boyer, D. S., Brown, D. M., Brucker, A. J., Cunningham, E. T., Heier, J. S., Holekamp, N. M., Kaiser, P. K., et al. (2024) · Retina · doi:10.1097/iae.0000000000004087 · Cited by 14
“2,5,11,22 25 Other suprachoroidally administered therapies being studied in clinical trials include CLS-AX (axitinib injectable suspension, a tyrosine kinase inhibitor with pan-vascular endothelial growth factor (VEGF) inhibition; NCT04626128) for macular degeneration, RGX-314 (adeno-associated…”
BackgroundUpdate on current pharmacologic therapies for diabetic retinopathy
Muns, S. M., Villegas, V. M., Flynn, H. W., & Schwartz, S. G. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2230139 · Cited by 16
Challenges in AAV-Based Retinal Gene Therapies and the Role of Magnetic Nanoparticle Platforms
Siontas, O., & Ahn, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237385 · Cited by 13
“The injection can be performed with standard needles but demands a highly skilled operator, which is why special transscleral microneedles or microcannulation with a flexible microcatheter are being commonly used [107,108].”
Cell-cell interaction in the pathogenesis of inherited retinal diseases
Du, X., Butler, A. G., & Chen, H. Y. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1332944 · Cited by 12
“…the choroid has also been shown to be a safe approach in preclinical and clinical studies yet it poses risk to spread viral vectors into the systemic circulation and could lead to adverse physical and immune response (Kansara et al., 2020; Naftali Ben Haim and Moisseiev, 2021; Tan et al., 2021).”
BackgroundSurgical Approaches to Retinal Gene Therapy: 2025 Update
Patel, M. J., Sheth, S., Mar, J., Gregori, N. Z., & Sengillo, J. D. (2025) · Bioengineering · doi:10.3390/bioengineering12101122 · Cited by 12
“While this approach utilizes readily available materials, it is heavily dependent on surgeon expertise with significant risk of injecting into unintended structures [55].”
A Novel Device for Suprachoroidal Drug Delivery to Retina: Evaluation in Nonhuman Primates
Rotenstreich, Y., Sher, I., Lawrence, M. S., Mangelus, M., Ingerman, A., & Barak, Y. (2023) · Translational Vision Science & Technology · doi:10.1167/tvst.12.6.3 · Cited by 8
Retinoid dynamics in vision: from visual cycle biology to retina disease treatments
Swigris, J., Widjaja‐Adhi, M. A. K., & Golczak, M. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108902 · Cited by 8
Tabl, A. A., Elsayed, M. A., & Tabl, M. A. (2022) · European Journal of Ophthalmology · doi:10.1177/11206721221085420 · Cited by 7
A Review on Polymeric Nanostructured Micelles for the Ocular Inflammation-Main Emphasis on Uveitis
Kumar, M., Kaushal, N., Singh, A., Tiwari, A., Tiwari, V., & Pahwa, R. (2022) · Pharmaceutical Nanotechnology · doi:10.2174/2211738511666221019160908 · Cited by 8
Zhang, D., & Zhu, D. (2022) · International Journal of Ophthalmology · doi:10.18240/ijo.2022.12.18 · Cited by 8
Suprachoroidal Triamcinolone Acetonide Injection to Treat Macular Edema: A Review
Rahman, S., Tayyab, H., & Siddiqui, M. A. R. (2024) · Journal of VitreoRetinal Diseases · doi:10.1177/24741264241275271 · Cited by 9
Suprachoroidal Drug Delivery for Macular Edema Associated With Noninfectious Uveitis
Huang, Y., Choo, C. H., Hancock, S. E., Ciulla, T. A., Wykoff, C. C., Shantha, J. G., & Yeh, S. (2024) · Journal of VitreoRetinal Diseases · doi:10.1177/24741264241246314 · Cited by 5
“14,15 In addition, topical treatments are highly concentrated in the anterior segment and increase the risk for corticosteroid-associated cataracts.”
Retinal findings in glomerulonephritis
Mack, H. G., Colville, D. J., Harraka, P. A., Savige, J. A., Invernizzi, A., & Fraser‐Bell, S. (2021) · Clinical and Experimental Optometry · doi:10.1080/08164622.2021.2003691 · Cited by 7
“Novel ocular delivery mechanisms are also in development, including a refillable port system(121) and injections and implants in the suprachoroidal space.(122)”
BackgroundDiress, M., Ionescu, C. M., Foster, T., Lim, P., Sen, L. Y., Kovačević, B., Wagle, S. R., Mooranian, A., & Al‐Salami, H. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107172 · Cited by 5
Song, L., Ren, C., Luo, M., Su, J., Jin, X., Fu, J., Xu, Q., Wu, X., Liu, F., Ye, Q., et al. (2025) · MedComm · doi:10.1002/mco2.70433 · Cited by 4
Choi, J., Shim, S., Shin, J., Lee, A., Strang, J., Braun, T., Naef, R., & Jung, H. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.03.024 · Cited by 18
“The suprachoroidal space (SCS), a potential space between the sclera and choroid normally sealed due to intraocular pressure and the eye ’ s fiber network, is a promising route to overcome these limitations and efficiently target PSE [8].”
Retinal BMI1 Expression Preserves Photoreceptors in Sodium-Iodate-Induced Oxidative Stress Models
Lu, Z., Liu, S., Morales, M. G., Whitlock, A., Ramkumar, R., & Ramkumar, H. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125907 · Cited by 6
Haddadzadegan, S., Mehdizdeh, N., Wang, X., Wong, T. T. L., & Miserez, A. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114841 · Cited by 5
Recent progress in polymeric micelle-Enabled targeted Nanotherapeutics for diabetic retinopathy
Sil, D., Kumar, D., Kurmi, B. D., & Kumar, M. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106448 · Cited by 6
Jung, K. L., Pecaku, A., Demian, S., Cruz-Pimentel, M., Melo, I. M., & Muni, R. H. (2024) · Retina · doi:10.1097/iae.0000000000004349 · Cited by 4
Brooks, D. E., Linares-Alba, M. A., García‐Santisteban, R., Xie, E., Gum, G. G., Manza, L. L., Servitje-Azcarraga, L., Santisteban, D. G., & García‐Sánchez, G. A. (2022) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2022.0030 · Cited by 3
Nawar, A. E., Ali, A., Massoud, O. M., & Alagorie, A. R. (2024) · Clinical ophthalmology · doi:10.2147/opth.s472910 · Cited by 3
“15,16 Suprachoroidal injection of steroids achieved more than 10-fold higher concentration in the retina and choroid and a lower concentration in the anterior segment structures (lens, iris and ciliary body) if compared to intravitreal injection.”
BackgroundA Novel Approach for Suprachoroidal Space Injection: An Experimental Evaluation
Long, J., Wu, X., Hu, P. F., Cui, N., Xu, L., Ye, Y., Chen, H., Peng, Q., Lu, X., & Long, D. (2025) · Current Eye Research · doi:10.1080/02713683.2025.2469829 · Cited by 2
“8 Unlike intravitreal injections, SCS injections are not impeded by restrictive membranes within the eye, typically resulting in higher therapeutic concentrations and gene transfection in target tissues.”
USE OF SUPRACHOROIDAL TRIAMCINOLONE ACETONIDE IN PEDIATRIC UVEITIS
Hanson, J., Moussa, K., Yamamoto, M. H., Hou, K. K., Pillar, S., Fung, S., Chen, J. L., Liao, A., Fayad, M., Tsui, I., et al. (2025) · Retinal Cases & Brief Reports · doi:10.1097/icb.0000000000001801 · Cited by 3
Iontophoretic drug delivery systems
Ansari, M. T., Srivastava, D., Kaliyappan, D., Tung, W. H., Sami, F. M., Khan, M. A. S., & Hasnain, M. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91864-0.00023-1 · Cited by 2
Doğanay, S., Gündüz, G. U., Kırıştıoğlu, M. Ö., Demirel, E., & Yalçınbayır, Ö. (2025) · Eye · doi:10.1038/s41433-024-03570-8 · Cited by 4
Karam, M., Baeshen, M., Abbas, K., Jamal, L., Maqwar, Z. B., Alotaibi, A., Alabduljalil, T., & Chen, J. J.-W. (2025) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-025-06880-z · Cited by 2
“This method potentially increases the concentration of drugs in the posterior segment of the eye while minimizing exposure to the anterior segment and crystalline lens [16].”
Feng, K., Wei, M., Ma, P., Hu, J., Huang, C., Han, Y., & Liu, Z. (2025) · Materials & Design · doi:10.1016/j.matdes.2025.114767 · Cited by 1
Zhang, D., Zhu, Q., Huang, R., Zhuang, A., & Zhu, D. (2025) · European Journal of Ophthalmology · doi:10.1177/11206721251379936 · Cited by 1
“12 However, access to the SCS is dif fi cult.”
Choe, S.-S., Ye, J., Zhang, T., & Gao, J. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202503757 · Cited by 1
Chen, M., Jiao, W., Liu, T., & Zhao, B. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1797383 · Cited by 1
“Higher viscosity prolonged SCS closure: increasing viscosity from 75,000 ± 35,000 cPs to around 200,000 cPs extended closure time from 19 min to 9.2 days (54–56).”
InfluentialDeep-sequencing-guided library screening and profiling of AAV capsids in the primate retina
Fouani, Y., Blazevic, D., Oti, M., Becker, R., Strobel, B., Schönberger, T., Stephan, M., Wichert, S., Reichel, F. F., Seitz, I. P., et al. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201764 · Cited by 1
FATIMA, M., ABBAS, S., & Sajjad, T. (2023) · Biological and Clinical Sciences Research Journal · doi:10.54112/bcsrj.v2023i1.290 · Cited by 2
“The supra-choroidal space is a unique passage for drug administration as it decreases drug concentration anteriorly and resultantly decreases the incidence of cataracts and elevated intraocular pressure (Naftali Ben Haim and Moisseiev, 2021).”
BackgroundJourieh, M. (2023) · touchREVIEWS in Ophthalmology · doi:10.17925/usor.2023.17.1.25 · Cited by 2
“Suprachoroidal injection is a promising, minimally invasive procedure for drug delivery to the posterior segment of the eye.(5) Many methods have been used to access the SCS, including a microcatheter, a standard hypodermic needle, a hollow microneedle, a custom-made needle and a microinjector.”
MethodPetrovic, N. T., Todorović, D., Srećković, S., Jovanovic, M., & Šarenac-Vulović, T. (2023) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh211016051p · Cited by 2
Pershakova, A. E., Kazakov, I. S., Artemov, M. A., Zolotarev, A. V., Жукова, О. В., Карлова, Е. В., Eroshevskaya, E. B., & Malov, V. M. (2023) · Aspirantskiy Vestnik Povolzhiya · doi:10.55531/2072-2354.2023.23.4.44-50 · Cited by 1
An Update on Suprachoroidal Corticosteroid Injections in the Management of Macular Edema
Ismail, O. M., & Henry, C. R. (2022) · Current Ophthalmology Reports · doi:10.1007/s40135-022-00291-7
“The length of the needle is approximately equivalent to the thickness of the sclera (900 or 1100 μm) [6, 8, 9].”
Treatments for diabetic retinopathy and diabetic macular edema in pipeline
Li, W., & Zhang, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-93064-2.00011-1
Intravitreal injection of methotrexate in persistent diabetic macular edema: a 6-month study
Razzaghpour, N., Najafi, A., Sabouri, M. R., Ashoori, N., & Shahraki, K. (2023) · Medical Hypothesis Discovery & Innovation in Ophthalmology · doi:10.51329/mehdiophthal1480
Khan, F. S., Asghar, A., haq, B. R. I. U., Nazir, T., Obaid, N., & Aslam, M. (2023) · Journal of Rawalpindi Medical College · doi:10.37939/jrmc.v27i4.2430 · Cited by 2
Therapeutic Evaluation of the Suprachoroidal Space for Stem Cell Delivery in Retinal Degeneration
Hyunhee, S. E. O., Lee, E., Kim, Y. Y., Ku, S., Yoon, C. K., & Park, K. H. (2026) · Stem Cells International · doi:10.1155/sci/1374159 · Cited by 1
“The clearance rates in SC injections are affected by molecular size, weight, and solubility [15, 23, 25, 26, 41].”
InfluentialEfficacy of Suprachoroidal Triamcinolone Acetonide Injections in Resistant Diabetic Macular Edema
Kumar, V., Memon, N. A., Haseeb, U., Kazi, U., Shah, S. H., & Qadeem, A. (2025) · Pakistan Journal of Health Sciences · doi:10.54393/pjhs.v6i5.2966
Advances in Deep Learning Applications for Choroidal Images Analysis: A Narrative Review
Shi, Y., Jiang, Z., Yang, Z., Chen, H., li, X., & Yang, J. (2026) · IET Image Processing · doi:10.1049/ipr2.70273
Gene therapy for wet AMD: a paradigm shift in the standard of care
Asanad, S., & Boyer, D. (2025) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2026.2651330
“They also limit exposure to the vitreous and anterior segments and provide compartmentalized AAV vector delivery, as seen in preclinical studies [3,5,8,9].”
Gene therapy development for retinal diseases
Reichel, F. F., Bellingrath, J.-S., Király, P., & FISCHER, M. D. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-443-22212-2.00016-1
Polymer used in 3D printed ocular drug delivery system
Mali, C., & Bagade, S. B. (2026) · International Journal of Polymeric Materials · doi:10.1080/00914037.2026.2682860
Bangar, P., Garkal, A., & Mehta, T. (2026) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2026.2691481
“…complex, improves durability of response, and may reduce ocular side effects such as cataract or intraocular pressure elevation. these advantages position suprachoroidal delivery as a potential long-acting treatment approach for wet AMD and other choroidal neovascular disorders [60,61].”
Advancing nanomaterials for treatment of eye diseases: a review
Amiryaghoubi, N., Sadeghi, M., Sadeghi, F., Amirsaadat, S., Jaymand, M., Akbari, M., Liu, G., & Jahanban, R. (2026) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2026.105087
Suprachoroidal triamcinolone acetonide for macular edema: A systematic review of efficacy and safety
Hedhiri, M. H., Oueslati, Y., Lajmi, H., Laajimi, F., Mbarek, S., Mahmoud, A., & Messaoud, R. (2026) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2026.105010
Metadata
- Authors
- Naftali Ben Haim, L., & Moisseiev, E.
- Affiliations
- Department of Ophthalmology, Meir Medical Center, Kfar Saba, 59 Tshernichovsky St., Kfar Saba 4428164, Israel
- Tel Aviv University (IL)
- ORCID
- Moisseiev, Elad
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2021-06-26
- Volume
- 13
- Issue
- 7
- Pages
- 967
- ISSN
- 1999-4923 (ISSN-L)
- PMC
- PMC8309112
- OpenAlex
- W3173820223
- Cited by
- 68
- References
- 111
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 12 · 2023: 16 · 2022: 11 · 2021: 2
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pharmaceutics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- suprachoroidal space, drug delivery, retinal disease, sclera, choroid, hollow microneedles, intravitreal injection, triamcinolone acetonide, non-infectious uveitis, macular edema, diabetic macular edema, gene therapy, viral vectors, non-viral vectors, posterior segment of the eye, pharmacokinetics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.